These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 9000358)

  • 1. MR imaging of hepatocellular carcinomas: effect of Cu and Fe contents on signal intensity.
    Honda H; Kaneko K; Kanazawa Y; Hayashi T; Fukuya T; Matsumata T; Maeda T; Masuda K
    Abdom Imaging; 1997; 22(1):60-6. PubMed ID: 9000358
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MR imaging of hepatocellular carcinoma. Correlation of metal content and signal intensity.
    Honda H; Onitsuka H; Kanazawa Y; Matsumata T; Hayashi T; Kaneko K; Fukuya T; Tateshi Y; Adachi E; Masuda K
    Acta Radiol; 1995 Mar; 36(2):163-7. PubMed ID: 7710797
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Small hepatocellular carcinoma: relationship of signal intensity to histopathologic findings and metal content of the tumor and surrounding hepatic parenchyma.
    Ebara M; Fukuda H; Kojima Y; Morimoto N; Yoshikawa M; Sugiura N; Satoh T; Kondo F; Yukawa M; Matsumoto T; Saisho H
    Radiology; 1999 Jan; 210(1):81-8. PubMed ID: 9885591
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MR imaging of small hepatocellular carcinoma: effect of intratumoral copper content on signal intensity.
    Ebara M; Watanabe S; Kita K; Yoshikawa M; Sugiura N; Ohto M; Kondo F; Kondo Y
    Radiology; 1991 Sep; 180(3):617-21. PubMed ID: 1651523
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Small hepatocellular carcinoma: assessment with T1-weighted spin-echo magnetic resonance imaging with and without fat suppression.
    Koushima Y; Ebara M; Fukuda H; Morimoto N; Sugiura N; Yoshikawa M; Sanada M; Saisho H; Matsumoto T; Yukawa M
    Eur J Radiol; 2002 Jan; 41(1):34-41. PubMed ID: 11750150
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of copper on MRI of hepatocellular carcinoma.
    Matsuzaki K; Sano N; Hashiguchi N; Yoshida S; Nishitani H
    J Magn Reson Imaging; 1997; 7(3):478-81. PubMed ID: 9170030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Small hepatocellular carcinoma on magnetic resonance imaging. Relation of signal intensity to angiographic and clinicopathologic findings.
    Honda H; Kaneko K; Maeda T; Kuroiwa T; Fukuya T; Yoshimitsu K; Irie H; Aibe H; Takenaka K; Masuda K
    Invest Radiol; 1997 Mar; 32(3):161-8. PubMed ID: 9055129
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatocellular carcinomas with excessive copper accumulation: CT and MR findings.
    Kitagawa K; Matsui O; Kadoya M; Takashima T; Kawamori Y; Yamahana T; Kidani H; Hirano M; Masuda S; Nakanuma Y
    Radiology; 1991 Sep; 180(3):623-8. PubMed ID: 1714611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The magnetic resonance and histological correlations in hepatocellular carcinoma].
    Bartolozzi C; Lencioni R; Caramella D; Paolicchi A; Russo R; Romani R
    Radiol Med; 1994; 87(1-2):90-5. PubMed ID: 8128039
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dysplastic nodules and hepatocellular carcinoma: thin-section MR imaging of explanted cirrhotic livers with pathologic correlation.
    Earls JP; Theise ND; Weinreb JC; DeCorato DR; Krinsky GA; Rofsky NM; Mizrachi H; Teperman LW
    Radiology; 1996 Oct; 201(1):207-14. PubMed ID: 8816545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Magnetic resonance imaging-histologic correlation of small hepatocellular carcinomas adenomatous hyperplasias.
    Inoue E; Kuroda C; Narumi Y; Fujita M; Kadota T; Kuriyama K; Yoshioka H; Ishiguro S; Sasaki Y; Imaoka S
    Invest Radiol; 1993 Aug; 28(8):691-7. PubMed ID: 8397170
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diffusion-weighted imaging of surgically resected hepatocellular carcinoma: imaging characteristics and relationship among signal intensity, apparent diffusion coefficient, and histopathologic grade.
    Nasu K; Kuroki Y; Tsukamoto T; Nakajima H; Mori K; Minami M
    AJR Am J Roentgenol; 2009 Aug; 193(2):438-44. PubMed ID: 19620441
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Small hepatocellular carcinomas in cirrhosis: differences in contrast enhancement effects between helical CT and MR imaging during multiphasic dynamic imaging.
    Hayashida M; Ito K; Fujita T; Shimizu A; Sasaki K; Tanabe M; Matsunaga N
    Magn Reson Imaging; 2008 Jan; 26(1):65-71. PubMed ID: 17566685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differentiation of well-differentiated hepatocellular carcinomas from other hepatocellular nodules in cirrhotic liver: value of SPIO-enhanced MR imaging at 3.0 Tesla.
    Park HS; Lee JM; Kim SH; Chang S; Kim SJ; Han JK; Choi BI
    J Magn Reson Imaging; 2009 Feb; 29(2):328-35. PubMed ID: 19161184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatocellular carcinoma in cirrhosis: enhancement patterns at dynamic gadolinium- and superparamagnetic iron oxide-enhanced T1-weighted MR imaging.
    Lutz AM; Willmann JK; Goepfert K; Marincek B; Weishaupt D
    Radiology; 2005 Nov; 237(2):520-8. PubMed ID: 16192317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Superparamagnetic iron oxide-enhanced magnetic resonance images of hepatocellular carcinoma: correlation with histological grading.
    Imai Y; Murakami T; Yoshida S; Nishikawa M; Ohsawa M; Tokunaga K; Murata M; Shibata K; Zushi S; Kurokawa M; Yonezawa T; Kawata S; Takamura M; Nagano H; Sakon M; Monden M; Wakasa K; Nakamura H
    Hepatology; 2000 Aug; 32(2):205-12. PubMed ID: 10915725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Additional value of SPIO-enhanced MR imaging for the noninvasive imaging diagnosis of hepatocellular carcinoma in cirrhotic liver.
    Yoo HJ; Lee JM; Lee JY; Kim SH; Kim SJ; Han JK; Choi BI
    Invest Radiol; 2009 Dec; 44(12):800-7. PubMed ID: 19838119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatocellular carcinoma: correlation of MR imaging and histopathologic findings.
    Kadoya M; Matsui O; Takashima T; Nonomura A
    Radiology; 1992 Jun; 183(3):819-25. PubMed ID: 1316622
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Value of gadoxetic acid-enhanced and diffusion-weighted MR imaging in evaluation of hepatocellular carcinomas with atypical enhancement pattern on contrast-enhanced multiphasic MDCT in patients with chronic liver disease.
    Kim HS; Kim SH; Kang TW; Song KD; Choi D; Park CK
    Eur J Radiol; 2015 Apr; 84(4):555-62. PubMed ID: 25617950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gadoxetic acid-enhanced hepatobiliary phase MRI and high-b-value diffusion-weighted imaging to distinguish well-differentiated hepatocellular carcinomas from benign nodules in patients with chronic liver disease.
    Lee MH; Kim SH; Park MJ; Park CK; Rhim H
    AJR Am J Roentgenol; 2011 Nov; 197(5):W868-75. PubMed ID: 22021534
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.